Developer of a cerium oxide-based nanozyme therapeutic designed to treat acute and chronic inflammatory diseases. The company offers enzyme-mimetic nanoparticles that catalytically eliminate reactive ...

Healthcare
Seoul, South Korea
Founded 2016
40 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$19.9M
Last Round
N/A

Get the full picture

Create a free account to unlock Cenyx Biotech's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required